Baltic Diabetes Cluster

Logo Baltic Diabetes Network

Diabetes mellitus is a civilization disease with vast consequences, for both patients and society and one of the most rapidly increasing diseases in the world.
Diabetes mellitus is associated with a multitude of pathological processes and conditions which arise in numerous tissues and organs, including the eye, the kidney, blood vessels and nerve tissues. Severe complications as blindness, amputation of extremities, kidney failure requiring dialysis menace diabetic patients. The probability to develop diabetes-induced complications is already given in the pre-diabetic stage of insulin resistance.
The disease is part of the so-called “deadly quartet” metabolic syndrome of hypertension, obesity, insulin resistance (or full-blown diabetes), and hypertriglyceridemia. 

During the last years, an overwhelming escalation in the incidence of diabetes was observed and results in significant challenges for public health, healthcare practitioners, health systems and insurances.The epidemic increases in this lifestyle disease require the replacement of current reactive and often isolated treatment strategies by an integrated and personalized diabetes management approach.

Baltic Diabetes Cluster is a special interest group, consisting of, practices, hospitals health tourism facilities as hotels and rehabilitation clinics, SMEs and representatives of academia and administration from Germany, Poland, and Lithuania (project partners in the EU South Baltic Region project Eco4Life), collaborating with institutions from the Northern Baltic Sea.
The aim of Baltic Diabetes Cluster is to develop a common transregional approach for integrated and personalized diabetes management in the whole Baltic Sea Region, according to the policy of the ScanBalt flagship project "Baltic Sea Health Region" as part of the EU Baltic Sea Strategy. ScanBalt is a leading network of clusters, universities, companies and public authorities working within life sciences to promote the Baltic Sea Region as a globally competitive Green valley and Health region.
At the 10th ScanBalt Forum 2011, the Baltic Diabetes Cluster was founded to foster cross-sectoral and cross-border collaboration in the Baltic Sea Region.

Mecklenburg-Vorpommern as Center of Competence for Diabetes mellitus in Germany is supposed to become pilot region for the Baltic Diabetes Cluster, with BioConValley® as central contact for life science and health economy in North Eastern Germany and coordinator of the initiative.
The federal state is closely linked to emerging health economies in Poland and the Baltics, as well as to the dynamic Medtech region in the North of the Baltic Sea.

Within the initiative, research institutions and SMEs intend to develop system solutions for the integrated and personalized diabetes management as well as for the diagnostics and treatment of diabetes-related complications (diabetic eye, diabetic foot). By bridging the gap between studies for innovations and health services research the impact of the new system solutions on the real-life situation of the patients and on the health care system will be established.


Find more information on the Network Website

A LinkedIn Group Baltic Diabetes Network (South) was founded to enable discussions between the cluster members.

GERMANY (Mecklenburg-Vorpommern)

Ambulantes Zentrum

Diabetes mellitus – prevention, treatment – active lifestyle

The ever-increasing incidence of diabetes mellitus worldwide owing to modern lifestyles does not mean that diabetes cannot be prevented or effectively treated.

On the contrary: both scientific research and clinical practice in this area around the globe demonstrate the importance of early diagnosis as the main goal in diabetes management. Regular check-ups for individuals in high-risk groups are considered to be of utmost importance. These high-risk groups include patients suffering from arteriosclerosis, hypertension and/or obesity, as well as the elderly.


BioArtProducts GmbH (B.A.P.)


The BioArtProducts GmbH is a service and consulting company with many years of service to medical facilities. The company operates primarily in the areas of medical research on extracorporeal detoxification, quality management in health care and the development of proprietary software for medical studies and registries. Also, the BioArtProducts GmbH supports health facilities to implement cross-sectoral collaborative  structures.



Thomas Zimmermann

BioArtProducts GmbH
Nobelstraße 52
18059 Rostock
Tel. 0381-40 50 254
Fax 0381-40 50 257


BioCon Valley GmbH


BioCon Valley GmbH has locations in Greifswald and Rostock to network companies, research facilities and clinics in the state. It serves as a central information hub and provides support for projects aiming to commercialize the latest research results in the region.

Dr. Heinrich Cuypers
BioCon Valley GmbH
International Contacts
Walter-Rathenau-Strasse 49a
D-17498 Greifswald, Germany
Phone: +49 3834 515 300
Fax: +49 3834 515 102



BIOMEDRO Biomedizinische Forschung und Entwicklung GmbH develops and produces a range of ELISA assays targeted at the determination of autoantibodies in human serum and plasma.

Biomedizinische Forschung und Entwicklung GmbH
Goethestraße 40
18209 Bad Doberan, Germany
Phone: +49 038203/7319-20
Fax.    +49 038203/7319-29


Cyberknife Logo




Hoffrichter GmbH


IMAGE Information Systems

EUROIMMUN Medizinische Labordiagnostika AG

EUROIMMUN produces reagents for medical laboratory diagnostics. In the foreground are test systems for the determination of various antibodies in patient serum in the diagnosis of autoimmune diseases, infectious diseases and allergies.

Branch Dassow
Werkstraße 2-22
D-23942 Dassow, Germany


Seekamp 31
D-23560 Luebeck, Germany

Contact:  Dr. Gabi Ommen


Phone:    +49 451 58 55 25 454



Gesundheitsinsel Rügen e.V.

Rügen – A health island with first-class infrastructure: its health resorts, clinics, quality hotels, mild bracing climate, attractive Baltic coast, unique natural paradise, sea buckthorn and healing chalk offer excellent conditions for combining a relaxing holiday with medical treatment and high-quality, health-related services. In addition healthcare professionals cooperate closely with experienced service providers in the tourism industry through a special network called “Health Island Rügen” (Gesundheitsinsel Rügen e.V.), offering health holidays for people

  • who would like to undergo a medical or therapeutic treatment – or require nursing care – during their holiday,
  • who, owing to a physical disability, require barrier-free facilities & services,
  • who live with a chronic illness and require personalised support
  • or who are simply health conscious and would like to plan a holiday with activities that help them maintain their health.


Group Practice for Dialysis and Apheresis Rostock


The Group Practice for Dialysis and Apheresis in Rostock was established in 2005 with the merger of two existing group practices specializing in internal medicine and nephrology.


Dr. Wolfgang Ramlow
St.-Petersburger Str. 18c
D-18107 Rostock
Praxisverbund für Dialyse und
Apherese (P.D.A.)
Phone: +49 381 40502-19
Fax: +49 381 4050234





HealthNet-MV‘s mission is to provide the best medical treatment with state-of-the-art procedures and technologies. The interdisciplinary approach of our highly qualified teams of doctors and nurses ensures the best possible care for you.

Jan Klaiber
Schillingallee 68
D-18057 Rostock
Phone: +49 381 49477 66
Fax: +49 381 49473 54



IMACO GmbH was founded in 1993. Since then they have specialised in blood-glucose monitoring systems and rapid tests for the OTC market.

Over the years they have developed a wide range of systems that provide reliable services to patients and doctors – depending on the application. Their systems are subject to strict quality tests. All products have been tested and approved in accordance with the current

ISO standard and the German Medical Association Guidelines (RiLiBÄK).

With their competence and know-how, they are able to provide expert advice to dispensing chemists and doctors. The products are recommended by German health insurance funds. (Cat. B of the Association of Substitute Health Insurance Companies (VdEK) agreement on the provision of medications)


Infokom GmbH


Infokom (founded in1991) offers customer-oriented full-range IT solutions. Our range of services includes consulting, software development and IT training, as well as the distribution, installation and management of hardware, software
and networks. We are proud of our international cooperative ventures and relationships, especially in the Middle East, the USA and China, as well as of our experience in sourcing, planning and running international pilot projects in the health sector.

Rolf-Dietrich Berndt
Informations- und
Kommunikationsgesellschaft mbH
Johannesstrasse 8,
D-17034 Neubrandenburg
Phone: +49 395 430520
Fax: +49 395 4305249


INP Leibniz-Institut für Plasmaforschung und Technologie e.V.


The Leibniz Institute for Plasma Science and Technology (INP Greifswald) is the largest non-university-affiliated
institute in the field of low-temperature plasmas, their basic principles and technical application in Europe.

Prof. Dr. Thomas von Woedtke
INP Greifswald e.V.
Felix-Hausdorff-Str. 2
D-17489 Greifswald
Phone: +49 3834 554300
Fax: +49 3834 554301


Inros Lackner

Inros Lackner AG

Institute of Diabetes “Gerhardt Katsch” Karlsburg


The internationally renowned Karlsburg Institute of Diabetes “Gerhard Katsch“ in Karlsburg , a former WHO
reference center for diabetes, has many years of experience in providing personalized support for doctors
and patients, in experimental and clinical research in type II diabetes research, in training doctors in diabetology, as well as in the general organization and coordination of outpatient and clinical support for diabetics.

Dr. Eckhard Salzsieder
Institute of Diabetes
“ Gerhardt Katsch“
Karlsburg e.V.
Greifswalder Str. 11e
D-17495 Karlsburg
Phone: +49 38355 68400
Fax: +49 38355 68444


Klinikum Karlsburg der Klinikgruppe Dr. Guth


Klinikum Karlsburg has a rich history and enjoys an excellent reputation in Mecklenburg-Vorpommern and Germany. In 1986 Klinikum Karlsburg was nominated the collaborating-center of the WHO. Today, the Cardiac and Diabetes
Center Mecklenburg-Vorpommern of Klinikum Karlsburg offers its patients state-of-the-art services in the entire field of cardiovascular medicine (cardiology, angiology, cardiac and vascular surgery) and all forms of diabetes care, including juvenile diabetes and associated diseases. Each year, roughly 2,500 cardiac and vascular surgeries and over 5,000 cardiological procedures are performed at the center. The diabetes clinic treats over 2,000 patients of all ages annually. The broad experience of our physicians and employees gives our patients peace of mind and ensures that their treatment will be successful.

Prof. Dr. med. Wolfgang Motz
Herz- und Diabeteszentrum
der Klinikgruppe Dr. Guth GmbH
& Co. KG
Greifswalder Str. 11
D-17495 Karlsburg




MEDIGREIF Inselklinik Heringsdorf GmbH


Logo Medigreif

Die MEDIGREIF Inselklinik Heringsdorf GmbH incorporates:
MEDIGREIF Inselklinik Heringsdorf GmbH, "Haus Gothensee", Specialist Clinic for Children and Adolescents with Metabolic, Psychosomatic and Skin Diseases
- Mütter-Gesundheit-Usedom e.V., Specialist Clinic for Mother-and-Child Convalescence
- MEDIGREIF Inselklinik Heringsdorf GmbH & Co. KG, "Haus Kulm", Specialist Clinic for Psychosomatic Medicine and Psychotherapy


Prof. Dr. med. habil. Ralf Schiel

MEDIGREIF Inselklinik Heringsdorf GmbH

Setheweg 11

D-17424 Ostseebad Heringsdorf, Germany

Phone +49-38378/780500

Fax +49-38378/780555




neoplas GmbH

neoplas puts its emphasis on the support of academic and industrial R&D. Our clients are public research
institutions and high technology companies:
· Expedient technology development
· Efficient technology management
· Effective technology marketing
neoplas closes the gap between the initial idea in the lab and the successful product launch on the market. Our experience enables us to overcome the numerous barriers of the highly complex technology transfer landscape and therefore achieves measurable results more quickly.
Typical research fields are plasma medicine, enzyme immobilization and biodecontamination.

Torge Vorhaben
neoplas GmbH
Walther-Rathenau-Str. 49a
17489 Greifswald
Phone: +49 3834 515 210
Fax: +49 3834 515 209


Oehm und Rehbein
Oehm und Rehbein

OR Technology (Oehm und Rehbein GmbH) has produced digital X-ray technology and developed image management systems for over 20 years. Our in-house solutions are used in private practices, hospitals and radiology. The successful track record includes more than 2000 installed image processing systems in over 50 countries.

OR Technology
(Oehm und Rehbein GmbH)
Neptunallee 7c
18057 Rostock
Phone: +49 381 36 600 500
Fax: +49 381 36 600 555

University of Applied Sciences Neubrandenburg


Since its foundation in 1991, the University of Applied Sciences Neubrandenburg has developed a special profile in the areas of research, development and knowledge transfer.

Prof. Dr. med. Dipl.-Soz.
Thomas Elkeles
FB Gesundheit, Pflege,
Sozialmedizin und Public Health
University of Applied Sciences
Brodaer Strasse 2
D-17033 Neubrandenburg
Phone: +49 395 56933103
Fax: +49 395 56933999


University Medicine Greifswald, Clinic and Policlinic for Gynaecology

Gestational diabetes affects 2-5% of all pregnant women. Because this condition can affect both mother and child, it is important to learn how to manage and control diabetes for the duration of the pregnancy.

Pregnant women diagnosed with gestational diabetes develop a condition referred to as insulin resistance, with inadequate control of blood sugar levels.

The treatment of gestational diabetes may include a special diet, exercise, blood glucose monitoring and/or insulin therapy.

The complications of gestational diabetes are usually manageable and preventable. Our interdisciplinary team of experts, including doctors specialising in maternal fetal medicine and internal medicine, nurses, diabetes educators and dieticians, provides a comprehensive treatment program to meet your special needs.

We also place a special emphasis on preventive care and life after gestational diabetes.


University Medicine Greifswald, Community Medicine

SHIP International – A federal concept to establish collaborative population-based research on common diseases

Study of Health in Pomerania  (SHIP)

SHIP is one of the leading epidemiological studies worldwide. The main purpose is to assess prevalence and incidence of common risk factors, subclinical disorders and clinical diseases and to investigate associations and interactions among them using comprehensive medical assessments. The assessments range from interview over laboratory analysis, somatometric and blood pressure measurements, dental, dermatological, cardio-metabolic and various ultrasound examinations to more demanding methods such as cardiopulmonary exercise tests, sleep monitoring and whole-body magnetic resonance imaging. The comprehensive data set offers various opportunities to assess the health status of the population on a very complex level and to perform association studies to gain new insight into the relations among risk factors, subclinical disorders and clinical diseases.


University Medicine Greifswald, Dep. Gastroenterology

Acute pancreratitis and diabetic patients

People with diabetes were more likely to have a number of risk factors for acute pancreatitis. Those included gallstones and heavy drinking — two of the most common causes of pancreas inflammation — as well as high triglycerides (a type of blood fat) and a history of the liver infections hepatitis B or C. But even when those conditions were taken into account, diabetes itself was linked to an 89 percent increase in the risk of acute pancreatitis.
Other factors that have been proposed to contribute to pancreatitis are obesity, diets high in animal protein and fat, as well as antioxidant deficiencies.


University Rostock University Eye Hospital


As part of the University of Rostock‘s Medical Center, the University Eye Clinic is also active in scientific research. In recent years it has been particularly successful in the use of lasers for ophthalmological applications, especially in the treatment of malicious diseases of the eye, eye socket and eyelids.

Universitätsaugenklinik Rostock
Direktor Prof. Dr. Rudolf F. Guthoff
Doberaner Strasse 140
D-18057 Rostock
Phone: +49 381 4945299
Fax: +49 381 4948502


University Rostock, Transplant Center

The transplant center at the University of Rostock, provides a broad spectrum of surgical services at a high level of competence. By specializing in different organ systems and by close collaboration between nationally and internationally recognized physicians and scientists, it is possible to implement the most modern treatment methods.


POLAND (Szczecin)

Hospital of Diabetology and Internal Medicine of Pomeranian Medical University in Szczecin

Types of the latest diagnostic and therapeutic procedures:
• the use of modern methods of insulinotherapy (functional insulinotherapy and personal insulin pumps) in patients with diabetes treated with insulin, including in women with gestational diabetes
• assessment of glycemic control using continuous glucose monitoring system
• assessment of new drugs used in diabetes
The development of modern standards of type 1 and 2 diabetes.


Hospital of Nefrology, Transplantology and Internal Medicine of Pomeranian Medical University in Szczecin

The core competencies are the diagnostics and treatment of

  • kidney diseases
  • patient care after kidney transplantation
  • renal failure treatment – hemodialysis and peritoneal dialysis

endocrynogic, metabolic and reumatoidal diseases.


Department of Public Health of Pomeranian Medical University in Szczecin


  • basic and applied research on genetic factors causing the most common forms of cancer
  • research on prophylactics, early detection and treatment of cancer
  • conducting and managing the registry of DNA samples and clinical data


Lithuanian Diabetes Association

The Lithuanian Diabetes Association LDA is a non- profit organization with the following aimes:

-        to provide mutual aid and assistance to all diabetics;

-        to promote the study, the spread of knowledge and the proper treatment of diabetes;

-        to remove all present limitations of diabetics discrimination in their rights to labour, studies, insurance.

The Lithuanian Diabetes Association plays the leading part in realization of the National Diabetes Programme of Lituania: by making representations to the government, the LDA helps to ensure that the standard of diabetes care is maintained.
At present the LDA comprises over 5 thousand members: Community of Nurses-diabetes teachers, representative offices of Companies rendering medical services such as Eli Lilly, Novo Nordisk, Medisana which provide assistance to the country fall under the membership of the LDA.

Dr. Vida Augustiniene
Head of Lithuanian Diabetes Association